2026-10-13 https://api.researchdata.se/oai-pmh

oai:researchdata.se:2023-183/1 2026-03-18 subject:ssif:30107 subject:ssif:30202 subject:ssif:30203 subject:ssif:301 subject:ssif:302 subject:ssif:3 principal:slug:karolinska-institutet

info:eu-repo/semantics/other http://purl.org/dc/dcmitype/Dataset https://doi.org/10.48723/hk61-4f76 Data generated for "Serial MRD assessment predicts relapse after transplantation in patients with myelodysplastic syndrome. Data genererad för "Serial MRD assessment predicts relapse after transplantation in patients with myelodysplastic syndrome" https://orcid.org/0000-0002-3633-5852 https://ror.org/056d84691 Karolinska University Hospital 0000-0002-3633-5852 Medical Genetics and Genomics Medicinsk genetik och genomik Hematology Hematologi Cancer and Oncology Cancer och onkologi The study has evaluated the association between measurable residual disease (MRD) determined using digital droplet PCR (ddPCR) and outcome after allogeneic stem cell transplantation for patients with myelodysplastic syndrome (MDS). The patient-specific mutations have been identified using next generation sequencing (NGS). The dataset contains: 1. NGS data 2. MRD data 3. List of ddPCR-assays 4. Variants for ddPCR only identified at diagnosis 5. Variants of undetermined significance targeted by ddPCR 6. Regression analyses Studien har utvärderat relationen mellan kvarvarande sjukdom (MRD) undersökt med digital droplet PCR (ddPCR) och utfall efter allogen stamcellstransplantation för patienter med myelodysplastiskt syndrom (MDS). De patient-specifika mutationerna har identifierats med en NGS-panel. Följande data finns: 1, NGS-data 2. MRD-data 3. Lista på ddPCR-assays 4. Varianter för ddPCR bara identifierad vid diagnos 5. Varianter av oklar signifikans analyserat för ddPCR 6. Resultat av regressionsanalyser info:eu-repo/semantics/restrictedAccess Karolinska Institutet Karolinska Institutet 2024-08-23T12:54:03.412122Z eng